Lars Stavenow
Impact in
-
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Geriatrics and Gerontology top 5%
Papers in
-
- Cardiovascular Health and Disease Prevention 7
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Cardiovascular Disease and Adiposity 5
- Co-authors
- Folke LindgärdeBo HedbladPeter LindLars JanzonGunnar EngströmG BerglundArtur FedorowskiOlle Melander
- Journals
- Journal of Internal Medicine (7 papers)Scandinavian Journal of Clinical and Laboratory Investigation (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Circulation (4 papers)Atherosclerosis (3 papers)
- Partner nations
- SwedenUnited StatesGreece
In The Last Decade
Lars Stavenow
83 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 130
- Cardiology and Cardiovascular Medicine 973
- Geriatrics and Gerontology 77
- Pulmonary and Respiratory Medicine 587
- Physiology 465
- Epidemiology 588
Countries citing papers authored by Lars Stavenow
This map shows the geographic impact of Lars Stavenow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Stavenow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Stavenow more than expected).
Fields of papers citing papers by Lars Stavenow
This network shows the impact of papers produced by Lars Stavenow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Stavenow. The network helps show where Lars Stavenow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Stavenow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 16 | |
| 2 | 2015 | 34 | |
| 3 | 2013 | 15 | |
| 4 | 2012 | 37 | |
| 5 | 2003 | 6 | |
| 6 | 2003 | 47 | |
| 7 | 1999 | 31 | |
| 8 | 1996 | 74 | |
| 9 | 1996 | 16 | |
| 10 | 1995 | 3 | |
| 11 | 1994 | 1 | |
| 12 | 1993 | 1 | |
| 13 | 1992 | 39 | |
| 14 | 1992 | 8 | |
| 15 | 1991 | 20 | |
| 16 | 1989 | 37 | |
| 17 | Effects of polycyclic aromatic hydrocarbons on proliferation, collagen secretion and viability of arterial smooth muscle cells in culture. | 1988 | 17 |
| 18 | Patients with reversible ischemic neurological deficit (RIND) have less severe carotid artery lesions than those with transient ischemic attack (TIA) evaluated by duplex ultrasound. | 1988 | 5 |
| 19 | 1986 | 1 | |
| 20 | Growth stimulating activity from lysed cultured arterial smooth muscle cells and skin fibroblasts. | 1985 | 3 |
About Lars Stavenow
Lars Stavenow is a scholar working on Cardiology and Cardiovascular Medicine, Geriatrics and Gerontology, Biochemistry, Hematology and Endocrinology, Diabetes and Metabolism, having authored 83 papers that have together received 2.7k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (14 papers), Blood properties and coagulation (11 papers), Cerebrovascular and Carotid Artery Diseases (7 papers), Cardiovascular Health and Disease Prevention (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Antioxidant Activity and Oxidative Stress (6 papers) and Cardiovascular Disease and Adiposity (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (973 citations), Geriatrics and Gerontology (77 citations), Pulmonary and Respiratory Medicine (587 citations), Physiology (465 citations) and Epidemiology (588 citations). Lars Stavenow has collaborated with scholars based in Sweden, United States and Greece. Frequent co-authors include Folke Lindgärde, Bo Hedblad, Peter Lind, Lars Janzon, Gunnar Engström, G Berglund, Artur Fedorowski, Olle Melander, Bo Israelsson and P. M. Nilsson. Their work appears in journals such as Journal of Internal Medicine, Scandinavian Journal of Clinical and Laboratory Investigation, Arteriosclerosis Thrombosis and Vascular Biology, Circulation and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.